GlaxoSmithKline Pharmaceuticals CFO, Mr. Juby Chandy, Resigns

Mr. Juby Chandy, the Chief Financial Officer (CFO) and Whole-Time Director of GlaxoSmithKline Pharmaceuticals Ltd, has tendered his resignation, effective from the close of business hours on March 11, 2026. The resignation comes after his appointment as Finance Head for the Asia Pacific region at GSK. Mr. Chandy has expressed his gratitude to the Board of Directors and the Managing Director for their support and guidance during his tenure. The company will complete the necessary filings with the relevant Government Authorities and regulatory bodies.